17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.

Chronic administration of 17beta-oestradiol (via drinking water) or the oral contraceptive Enovid (norethynodrel and mestranol) (0-1 mg injected s.c. twice weekly) to nulliparous C3H/HeJ female mice, beginning at one month of age and terminating at 20 months (17beta-oestradiol) or 22 months (Enovid)...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsch, C. W., Adams, C., Lambrecht, L. K., Hassett, C. C., Brooks, C. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1977
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025270/
https://www.ncbi.nlm.nih.gov/pubmed/576837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025270/
https://www.ncbi.nlm.nih.gov/pubmed/576837

Ejemplares similares